Press "esc" to clear
Go to Advanced Search

Showing results

110 of 177

Article ID: 697435

Researchers Shrink Tumors in Mice by Manipulating Brain's Reward System

American Technion Society

Researchers at the Technion-Israel Institute of Technology have successfully shrunk cancerous tumors in mice by manipulating the brain’s reward system. The intervention caused the nervous system to stimulate the immune system.

Released:
16-Jul-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 696440

The Immune System: Cracking Open the Black Box

American Technion Society

A technology developed at Israel's Technion will provide the scientific community with novel tools to gain a comprehensive understanding of immune system activity. Based on millions of scientific publications, the technology uses artificial intelligence to map disease immune profiles. These maps, which have already identified previously unknown biological interactions, will enable development of personalized, immuno-centric therapies

Released:
21-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 696269

Researchers Generate Electricity and Hydrogen from Live Bacteria

American Technion Society

Using a family of photosynthetic bacteria that commonly live in lakes and seas, researchers at the Technion have developed a technology to generate electricity and hydrogen energy. The researchers believe their technology can serve as a promising source of clean, environment-friendly energy that will not emit pollutants during production or use (hydrogen fuel).

Released:
18-Jun-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 695647

Nanotechnology for Plant Nutrition

American Technion Society

Technion researchers have found they can significantly increase agricultural yields, by using nanoscale delivery platforms that until now were used to transport drugs to specific targets in a patient's body. The technology increases the penetration rate of nutrients into the plant, from 1% to approximately 33%.

Released:
5-Jun-2018 4:20 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 695334

A New Way to Deliver Anticancer Drugs to Pediatric Tumors

American Technion Society

A newly developed nanosystem significantly improves the effectiveness of anti-cancer drugs and reduces the required dosage by about 90%. The system could offer a glimpse of developments to come in the treatment of pediatric cancers, which differ from adult cancers in aspects that include genetic characteristics, growth patterns and developmental pathways.

Released:
30-May-2018 4:15 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 695038

Israeli and American Researchers Have Successfully Curbed Mesothelioma in Model Animals

American Technion Society

A team led by researchers from the Technion and NYU Langone has successfully impeded the development of mesothelioma - a disease for which there is currently no effective treatment. Mesothelioma, a cancer that develops in the thin membrane that protects the internal organs of the chest and abdomen, is in most cases caused by exposure to asbestos.

Released:
23-May-2018 2:45 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 694596

Wearable Devices for Early Disease Monitoring and Diagnosis

American Technion Society

Researchers at the Technion have developed an integrated system for early diagnosis of diseases through the use of wearable monitors. The system is able to repair itself in the event of a tear or scratch, and receives the energy required for operation from the wearer.

Released:
15-May-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 693756

Optimal Propulsion: Helping Nanoscale Robots Swim Better

American Technion Society

Researchers from the Technion have completed an interdisciplinary study that reveals the optimal configuration for nanoscale robots that can travel within the human body to perform a variety of tasks. The model improves previous nature-inspired models.

Released:
30-Apr-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 691419

Cats Could Help in Development of Anti-HIV Drugs

American Technion Society

Technion researchers have discovered a mechanism which may serve the foundation for the resistance of FIV, the virus that causes “Feline AIDS.” Because of the parallels between FIV and HIV-1, the researchers say the discovery could also assist in the ongoing fight against AIDS.

Released:
19-Mar-2018 9:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 689969

Using Light and Gold for Targeted, Non-Invasive Drug Delivery

American Technion Society

Researchers have developed a highly-targeted and non-invasive drug-release method that combines a nanoscale gold particle-containing polymer coating and near-infrared light. The technology could also be used for other applications, including the sealing of internal and external injuries, and as biodegradable scaffolds for growing transplant organs.

Released:
22-Feb-2018 9:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Showing results

110 of 177





Chat now!